Home » healthcare policy

Adderall Shortage Persists Into 2026 — Modest DEA Quota Increase Offers Limited Relief

The ongoing Adderall shortage in the U.S. has persisted since late 2022, causing inconsistent access for patients. Although the DEA increased production limits for stimulants, manufacturing delays and supply chain issues complicate availability. Patients are urged to plan refills early while advocates continue to push for systemic changes to address this crisis.

Adderall Shortage Persists Into 2026 — Modest DEA Quota Increase Offers Limited Relief Read More

DOJ Files False Claims Act Suit Against Priority Hospital Group Over Alleged Medicare Fraud

The U.S. Department of Justice filed a civil complaint against Priority Hospital Group for submitting false Medicare claims through improper billing practices. Allegations include manipulating patient admissions and billing classifications for higher reimbursements, violating the False Claims Act. This case emphasizes accountability in healthcare while navigating complex Medicare regulations.

DOJ Files False Claims Act Suit Against Priority Hospital Group Over Alleged Medicare Fraud Read More

Congress Strikes Rare Health Care Deal Targeting Drug Middlemen

Congress has reached a rare bipartisan agreement targeting pharmacy benefit managers (PBMs) to improve transparency and accountability in drug pricing. The legislation aims to limit practices that inflate costs, protect independent pharmacies, and strengthen regulatory oversight, marking a significant health policy advancement without imposing direct price controls.

Congress Strikes Rare Health Care Deal Targeting Drug Middlemen Read More

The Adderall Shortage Isn’t an Accident—It’s a Policy Failure

The ongoing Adderall shortage, affecting Americans with ADHD since late 2022, results from regulatory failures and mismatched supply and demand. Rising ADHD diagnoses, increased telehealth access, and reduced stigma highlighted the need for flexible production quotas. Patients face significant disruptions, impacting their performance and well-being, while effective governance remains elusive.

The Adderall Shortage Isn’t an Accident—It’s a Policy Failure Read More

Congress Moves to Rein In Military Health System Overhaul Amid Deepening Readiness Concerns

Congress is demanding transparency from the Pentagon regarding the restructuring of the military health system. The FY2026 NDAA includes strict oversight to address concerns about troop readiness amid ongoing efforts by the Defense Health Agency to downsize facilities. The military’s wartime medical capabilities are reportedly in jeopardy, prompting urgent reforms.

Congress Moves to Rein In Military Health System Overhaul Amid Deepening Readiness Concerns Read More